Navigating Pharmaceutical Ambitions

This chapter explores Novartis' strategy to expand its cardiovascular drug pipeline through a significant M&A deal, while reflecting on past successes and market challenges. It also addresses the impact of legislative changes on drug development and the importance of sustainable growth in the current healthcare landscape.